Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms.

Hanley, Colleen M

Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms. [electronic resource] - Circulation. Arrhythmia and electrophysiology Mar 2016 - e002479 p. digital

Publication Type: Journal Article; Review

1941-3084

10.1161/CIRCEP.115.002479 doi


Action Potentials
Animals
Anti-Arrhythmia Agents--adverse effects
Atrial Fibrillation--diagnosis
Drugs, Investigational--adverse effects
Heart Conduction System--drug effects
Heart Rate--drug effects
Humans
Molecular Targeted Therapy
Treatment Outcome